Simultaneous Engagement of Networks for Alleviating Pain (SENAP) (NCT07057206) | Clinical Trial Compass
Not Yet RecruitingPhase 1
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
United States20 participantsStarted 2026-07-01
Plain-language summary
This trial is investigating the acceptability and efficacy of PFM-guided cortical stimulation for the treatment of central neuropathic pain.
Who can participate
Age range
22 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 22 years
* Clinical diagnosis of a refractory chronic neuropathic pain syndrome suggestive of deafferentation or central pain. Non-limiting examples of these syndromes are:
* post-traumatic pain syndromes (e.g. plexopathies, radiation-induced injury)
* postsurgical pain syndromes (e.g. phantom limb pain, anesthesia dolorosa)
* postherpetic neuralgia
* Central pain syndromes (e.g. post-stroke pain, multiple sclerosis pain, post-radiation pain)
* Greater than 6 months of chronic neuropathic pain
* Average pain intensity over the past 30 days reported as 6 or greater on a 0-10 numeric rating scale (NRS)
* Multidisciplinary pain consensus review that establishes
* Pain is refractory to medical management
* Pain that is refractory to or unlikely to be altered by less invasive treatment and
* Pain distribution either does not permit attempts at relief by a targeted nerve block (e.g., post-stroke pain) or such blocks have provided \<25% relief.
* Medication doses currently stable (no active titration or drug trials in progress) in the 30 days prior to baseline (immediately pre-surgical) study visit
* Ability to speak / read English
* Capable of understanding and providing informed consent (verified if necessary by a standard tool such as the MacArthur Competency Assessment)
* Women of childbearing age must be on regular use of an accepted contraceptive method(s).
Exclusion Criteria:
* Pregnancy, breastfeeding, or unwilling to maintain regular use of co…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.